Edwards Lifesciences Corp (EW)
89.14
-0.97
(-1.08%)
USD |
NYSE |
May 17, 16:00
89.15
+0.01
(+0.01%)
Pre-Market: 20:00
Edwards Lifesciences Research and Development Expense (Quarterly): 285.20M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 285.20M |
| December 31, 2023 | 270.00M |
| September 30, 2023 | 270.30M |
| June 30, 2023 | 270.30M |
| March 31, 2023 | 261.20M |
| December 31, 2022 | 232.20M |
| September 30, 2022 | 233.60M |
| June 30, 2022 | 250.80M |
| March 31, 2022 | 228.60M |
| December 31, 2021 | 232.80M |
| September 30, 2021 | 238.00M |
| June 30, 2021 | 225.30M |
| March 31, 2021 | 207.00M |
| December 31, 2020 | 195.70M |
| September 30, 2020 | 195.50M |
| June 30, 2020 | 182.10M |
| March 31, 2020 | 187.40M |
| December 31, 2019 | 193.90M |
| September 30, 2019 | 195.50M |
| June 30, 2019 | 191.90M |
| March 31, 2019 | 171.40M |
| December 31, 2018 | 163.10M |
| September 30, 2018 | 161.80M |
| June 30, 2018 | 154.10M |
| March 31, 2018 | 143.20M |
| Date | Value |
|---|---|
| December 31, 2017 | 146.60M |
| September 30, 2017 | 142.90M |
| June 30, 2017 | 134.40M |
| March 31, 2017 | 128.70M |
| December 31, 2016 | 114.90M |
| September 30, 2016 | 113.00M |
| June 30, 2016 | 147.00M |
| March 31, 2016 | 101.80M |
| December 31, 2015 | 98.00M |
| September 30, 2015 | 101.00M |
| June 30, 2015 | 97.50M |
| March 31, 2015 | 86.40M |
| December 31, 2014 | 94.20M |
| September 30, 2014 | 87.60M |
| June 30, 2014 | 89.10M |
| March 31, 2014 | 85.80M |
| December 31, 2013 | 78.60M |
| September 30, 2013 | 84.10M |
| June 30, 2013 | 80.50M |
| March 31, 2013 | 79.80M |
| December 31, 2012 | 74.90M |
| September 30, 2012 | 73.80M |
| June 30, 2012 | 74.00M |
| March 31, 2012 | 68.60M |
| December 31, 2011 | 60.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
182.10M
Minimum
Jun 2020
285.20M
Maximum
Mar 2024
227.36M
Average
230.40M
Median
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp | 368.00M |
| Align Technology Inc | 91.86M |
| Abbott Laboratories | 684.00M |
| Boston Scientific Corp | 366.00M |
| Steris PLC | 27.46M |